Wyden Introduces S. 420 to Legalize Cannabis
Legislative package also empowers states to implement own marijuana laws Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today announced introduction of S. 420, the Marijuana Revenue and Regulation Act, legislation that would responsibly legalize, tax and regulate marijuana at the federal level. This legislation is one of three bills introduced in […]
Wyden to Treasury: Don’t Penalize Taxpayers For Administration’s Mistakes on Withholding
As Prepared for Delivery M. President, the first tax filing season under Trump’s tax law is upon us, and it looks like a whole lot of chickens are coming home to roost. Republicans jammed their bill through the Congress at record speed. Pile-driver legislating. The bill was signed into law with a whopping nine days […]
Wyden, Blunt Introduce Craft Beverage Modernization and Tax Reform Act
Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., and Senator Roy Blunt, R-Mo., today introduced legislation to help ensure the continued growth of America’s craft beverage industry. The Craft Beverage Modernization and Tax Reform Act would permanently establish reduced taxes and modernized regulations for brewers, cider makers, vintners and distillers to further […]
Wyden Response to Trump State of the Union Trade Agenda
Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued the following statement in response to Donald Trump’s trade agenda in the State of the Union: “While I agree with Trump that America needs to do better on trade, so far his administration has done far more to create chaos and uncertainty than deliver results […]
Wyden Statement at Finance Committee Markup on Pending Nominations
The Finance Committee meets this morning to organize for the 116th Congress, adopt committee rules, and vote on four nominations. First let me thank all our members for their interest in joining Finance Subcommittees. I’d note there will be more members on the Finance Subcommittee on Health Policy than on the entire Senate Judiciary Committee, […]
Wyden, Schumer, Brown Call on Secretary Mnuchin to Press Chinese Trade Negotiators on Enforcement to Combat Predatory Trade Practices
Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., Senate Democratic Leader Chuck Schumer, D-N.Y., and Banking Committee Ranking Member Sherrod Brown, D-Ohio, sent a letter today urging Secretary Mnuchin to stay aggressive in his approach in ongoing negations with China. “We urge you to support a tough approach that demands meaningful, enforceable, […]
Wyden: Extreme Cold Poses Threats to Nursing Home Residents
Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today warned that the Trump administration’s efforts to roll back emergency preparedness standards for nursing homes endanger seniors who rely on these facilities to keep them safe in extreme weather, including this week’s “polar vortex.” Late last year, Wyden released Sheltering in Danger, a […]
Trump Proposal Threatens Due Process in Social Security Appeals
Washington, D.C. – Top Democrats responsible for Social Security policy in the House and Senate today called on the Social Security Administration to withdraw a proposed rule that would limit the right of Americans to receive an in-person appeals hearing if their initial application for Social Security benefits is denied. Workers who are eligible to […]
Wyden Statement on HHS Proposed Rule on Drug Rebates
Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued a statement after the Department of Health and Human Services (HHS) released a proposed rule that changed how pharmacy benefit managers (PBMs) can use drug rebates in federal health care programs: “For years I’ve said the middlemen have no accountability and consumers don’t see any […]
Wyden: Pharma Execs Must Come to Congress
Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today called on drug makers to come before Congress to explain to the public why drug prices have increased so much in recent years. “The Finance Committee invited the heads of several of the largest drug companies to testify today. They weren’t willing to […]